2002年
 2003年
 2006年
  第1期
  第2期

 
现在位置:首页 > 医学版 > 期刊论文 > 肿瘤学 > 临床肿瘤学杂志 > 2006年
2006年 
第1期
 
    07-04-10 Assessing BRCA Carrier Probabilities in Extended Families
    07-04-10 Correlates of Return to Work for Breast Cancer Survivors
    07-04-10 Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of
    07-04-10 Prognostic Significance of Chromosome Aberrations in High-Grade Soft Tissue Sarcomas
    07-04-10 Evaluation of Two Phosphorylation Sites Improves the Prognostic Significance of Akt Activation in Non–Small-Cell Lung Cancer Tumor
    07-04-10 Array-Based Comparative Genomic Hybridization Analysis Reveals Recurrent Chromosomal Alterations and Prognostic Parameters in Prim
    07-04-10 High Frequency of Submicroscopic Hemizygous Deletion Is a Major Mechanism of Loss of Expression of PTEN in Uveal Melanoma
    07-04-10 Tumor Necrosis Factor-–Induced Protein 3 As a Putative Regulator of Nuclear Factor-B–Mediated Resistance to O6-Alkylating Agents i
    07-04-10 EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the
    07-04-10 Gene Expression Profiling of Localized Esophageal Carcinomas: Association With Pathologic Response to Preoperative Chemoradiation
    07-04-10 New MUC1 Serum Immunoassay Differentiates Pancreatic Cancer From Pancreatitis
    07-04-10 Multipopulation Analysis of Polymorphisms in Five Mononucleotide Repeats Used to Determine the Microsatellite Instability Status o
    07-04-10 Vascular Endothelial Growth Factor-D and Its Receptor VEGFR-3: Two Novel Independent Prognostic Markers in Gastric Adenocarcinoma
    07-04-10 Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment E
    07-04-10 Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With C

第2期
 
    07-04-11 Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and V3-21 Usage Characterize Discordance of ZAP-70 and V
    07-04-10 White Matter Anisotropy in Post-Treatment Childhood Cancer Survivors: Preliminary Evidence of Association With Neurocognitive Func
    07-04-10 Analysis of Micrometastatic Disease in Sentinel Lymph Nodes From Resectable Colon Cancer: Results of Cancer and Leukemia Group B T
    07-04-10 Community-Based Use of Chemotherapy and Hormonal Therapy for Early-Stage Breast Cancer: 1987-2000
    07-04-10 Characterization of BRCA1 and BRCA2 Mutations in a Large United States Sample
    07-04-10 Identification in Administrative Databases of Women Dying of Breast Cancer
    07-04-10 Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care
    07-04-10 Subtype and Prognostic Classification of Rhabdomyosarcoma by Immunohistochemistry
    07-04-10 Serum YKL-40 Predicts Relapse-Free and Overall Survival in Patients With American Joint Committee on Cancer Stage I and II Melanom
    07-04-10 BAALC Expression and FLT3 Internal Tandem Duplication Mutations in Acute Myeloid Leukemia Patients With Normal Cytogenetics: Progn
    07-04-10 Defining Molecular Profiles of Poor Outcome in Patients With Invasive Bladder Cancer Using Oligonucleotide Microarrays
    07-04-10 Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer
    07-04-10 Antibody Immunity to the p53 Oncogenic Protein Is a Prognostic Indicator in Ovarian Cancer
    07-04-10 Preoperative Serum Tissue Factor Levels Are an Independent Prognostic Factor in Patients With Ovarian Carcinoma
    07-04-10 Association of Activated Transcription Factor Nuclear Factor B With Chemoradiation Resistance and Poor Outcome in Esophageal Carci